Zevra Therapeutics, Inc.
Pharmaceutical Preparations · Boston, MA, United States
- PrincipalsAdrian W QuartelChief Medical OfficerJustin A RenzCFONeil F. McFarlanePresident and CEOand 5 more
- CompanyZevra Therapeutics, Inc.Boston, MA, United States
- Phone line+1 (888) 958-1253General business
Zevra Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker ZVRA) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 8
Chief executive
Neil F. McFarlanePresident and CEO
Legal
Rahsaan ThompsonChief Legal & Compliance
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Justin A Renz — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Timothy J. Sangiovanni — SVP, Finance & Corp Controller
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Adrian W Quartel — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Neil F. McFarlane — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Teva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capabilityZai Lab LtdPharmaceutical Preparations · Shanghai1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityuniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capability